B. Peri ´c , N.P. Juraj, G. Szalontai et al.
Journal of Molecular Structure 1234 (2021) 130157
of the non-protonated carbons and the methyl groups appear in
the CPNQS spectra. Chemical shift calibration: to external l-alanine
methyl signal = 20.5 ppm relative to TMS. Samples used in ss-
NMR measurements were checked by powder X-ray diffraction on
a PANalytical Aeris instrument; [conditions Bragg-Brentano geom-
˚
etry (ꢀ–2ꢀ), source Cu-Kα (λ = 1.5418 A), measurement from 5°
to 70° (2ꢀ), with 5.2°/min (0.0216° step and 0.25 s/step)] (Figures
S13-S15 in Supplementary material).
Fig. 1. 2,3-, 2,5- and 2,6- isomers of diketopiperazines.
2
.2. Synthetic procedures
ther purification. Reactions were monitored by TLC on Silica Gel
The syntheses of the chloroacetamide precursors P1−P3 are de-
6
0 F254 plates and detected with a UV lamp (254 nm).
scribed in the Supporting Information [17,18].
NMR spectra in solution were obtained on a Bruker Avance
Synthesis of 1,4-diphenylpiperazine-2,5-diones 1–3, general
procedure [18]. A mixture of chloroacetamide (1 eq) and NaOH
(2 eq) in acetonitrile (50 mL) was stirred in a round bottom flask
and refluxed for 6 h. The solvent was evaporated in a vacuum, the
residue suspended in ethyl acetate and washed with water. The
suspension was filtered, the filter cake washed with water and col-
lected, affording 1,4-diphenylpiperazine-2,5-diones (1, 2 or 3).
3
00 or 600 spectrometer, operating at 300 or 600 MHz for 1
H
and on Bruker Avance 600 spectrometer operating at 150 MHz for
13C. If not mentioned otherwise, the spectra are recorded at room
temperature (Figures S1-S6 in Supplementary material). Chemical
shifts, δ (ppm), indicate a downfield shift from the residual sol-
vent signal (1.94 ppm CD CN, 2.50 ppm DMSO–d for 1H NMR,
3
6
1
18.26 ppm CD CN or 39.52 ppm DMSO–d6 for 13C NMR).
1,4-diphenylpiperazine-2,5-dione,
phenylacetamide, P1 (339.2 mg,
4 mmol). Yield: 117.8 mg (0.44 mmol, 44%), white powder,
1.
2-Chloro-N-
3
The mass spectrometric measurements were recorded either in
2 mmol), NaOH (160.0 mg,
the positive or negative ion mode using an Agilent Technologies
6
420 Triple Quad LC/MS (Agilent, USA) equipped for electrospray
Rf = 0.31 (2% methanol in dichloromethane). 1H NMR (600 MHz,
ionization source. The operating conditions for ESI were: nebulizer
gas (nitrogen) flow rate 0.2 mL/min; drying gas (nitrogen) flow rate
DMSO–d ) δ/ppm 7.47–7.41 (m, 8H, o-, m-Ph), 7.33–7.29 (m, 2H,
6
p-Ph), 4.51 (s, 4H, CH ). APT 13C NMR (151 MHz, DMSO–d ) δ/ppm
2
6
8
L/min (300 °C), the spray needle voltage was set to 3.5 kV (“cap-
164.06 (CO), 140.16 (Ph), 128.89 (Ph), 126.67 (Ph), 125.23 (Ph),
+
illary voltage”), the potential between the sampling cone and the
skimmer (“cone voltage”) was set to 135 V. The temperature in the
ion source was kept at 100 °C. Spectra were acquired at a step
size of 0.1 amu over a mass range of 10–2250 amu with a scan
time of 500 ms. Samples were dissolved in water–methanol sol-
vent 50:50 (v/v), at a concentration of 10 mg/mL, and the solutions
were directly infused into the electrospray source. The sample so-
lutions were introduced with a syringe pump at a flow rate of
52.76 (CH ). ESI-MS (m/z): 267.2 ([M+H] , 100%). MALDI-HRMS
2
+
(m/z): calcd for C16
H
N O 267.1128 [M+H] , found 267.1120. IR
14
2
2
(KBr) ν˜ /cm-1: 3473, 3059, 2947, 1654, 1592, 1497, 1469, 1450,
1432, 1317, 1252, 1142, 756, 692, 517, 495. Colorless prism-like
crystals suitable for single-crystal X-ray diffraction were obtained
from deuterated acetonitrile.
1,4-bis(4-nitrophenyl)piperazine-2,5-dione, 2. 2-Chloro-N-(4-
nitrophenyl)acetamide, P2 (429.2 mg, 2 mmol), NaOH (160.0 mg,
4 mmol). Yield: 153.3 mg (0.43 mmol, 43%), yellow powder,
Rf = 0.29 (2% methanol in dichloromethane). 1H NMR (600 MHz,
0.2 mL/min.
The MALDI-TOF/TOF mass spectra were obtained in the posi-
tive ion reflectron mode. Mass spectra of the compounds 1, 2 and
were accumulated using 50, 600 and 100 laser shots, respec-
DMSO–d ) δ/ppm 8.33–8.29 (m, 4H, Ph), 7.77 –7.73 (m, 4H, Ph),
6
3
4.70 (s, 4H, CH ). 13C NMR (151 MHz, DMSO–d ) δ/ppm 164.43
2
6
tively. All samples were analysed using CHCA (Sigma) as a matrix.
The CHCA matrix was prepared in a mixture of water-acetonitrile
(CO), 145.43 (Ph), 144.67 (Ph), 125.00 (Ph), 124.11 (Ph), 52.07 (CH ).
2
+
MALDI-HRMS (m/z): calcd for C16 H12N O 357.0830 [M+H] , found
4
6
5
0:50 (v/v) at a concentration of 10 mg/mL. The samples were pre-
357.0830. IR (KBr) ν˜ /cm-1: 3452, 3105, 3075, 1669, 1590, 1517,
1490, 1348, 1265, 1149, 857, 830, 733, 693, 603, 556, 546, 502,
411. Light yellow prism-like crystals suitable for single-crystal X-
ray diffraction were obtained by vapor diffusion of diethyl ether
into DMSO.
pared in the same solvent. Approximately 1 μL of the mixture
sample/matrix was deposited on the target plate (stainless steel)
and dried at room temperature.
IR spectra were recorded using KBr pellets with a Bruker Alpha
−1
FT-IR spectrometer, in the 4000–350 cm region (Figures S10-S12
in Supplementary material).
1,4-bis(4-(dimethylamino)phenyl)piperazine-2,5-dione, 3. 2-
Chloro-N-(4-(dimethylamino)-phenyl)acetamide, P3 (425.4 mg,
2 mmol), NaOH (160.0 mg, 4 mmol). The organic layer was evap-
orated, washed with acetone and combined with the filter cake.
Solid-state NMR (ssNMR) spectra were recorded on a Bruker
Avance II 400 spectrometer at Larmor frequencies of 400.13, 100.6,
and 40.56 MHz for 1H, 13C, and 15N, respectively; 4 mm MAS
probe using Zirconia rotors, rotation frequency: 5000–12,000 Hz.
Standard Bruker pulse sequences were used: 13C-, and 15N-CPMAS
Yield: 224.89 mg (0.64 mmol, 64%), brown powder, Rf = 0.18 (2%
1
methanol in dichloromethane). H NMR (600 MHz, CD CN) δ/ppm
3
7.19– 7.15 (m, 4H, Ph), 6.80–6.75 (m, 4H, Ph), 4.31 (s, 4H, CH ),
2
vacp, contact times 0.5–2 ms, relaxation delays 3–5 s), 13C CP-
2.94 (s, 12H, CH ). C NMR (151 MHz, CD CN) δ/ppm 165.27 (CO),
13
(
3
3
MAS with non-quaternary suppression (CPNQS), 13C MAS with
150.84 (Ph), 130.64 (Ph), 127.52 (Ph), 113.49 (Ph), 54.55 (CH ),
2
+
+
high-power proton decoupling (HPDEC). Notice that only signals
40.80 (CH ). ESI-MS (m/z): 705.5 [2M+H] , 353.3 ([M+H] , 100%).
3
Scheme 1. Synthesis of 1,4-diphenylpiperazine-2,5-diones 1–3. Reaction conditions: (a) NaOH, CH3CN.
2